Cover Image
市場調查報告書

全球風濕關節炎治療藥市場產品、開發平台分析

Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

出版商 Frost & Sullivan 商品編碼 319626
出版日期 內容資訊 英文 65 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球風濕關節炎治療藥市場產品、開發平台分析 Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
出版日期: 2014年11月20日 內容資訊: 英文 65 Pages
簡介

全球風濕關節炎治療藥市場,預計由於新的口服藥上市將大幅變化。

本報告提供全球的風濕關節炎治療藥市場的最新技術與市場趨勢的分析、目前臨床實驗的進展,及各臨床實驗階段、各類藥物的開發中產品(藥物候補)的一覽、臨床實驗的最後階段的藥物簡介、專利失效的時間表、已上市產品簡介,今後的新產品上市預測等調查評估。

第1章 摘要整理

  • 主要調查結果
  • 值得注意的企業
  • 未來的醫療趨勢定義
  • 摘要整理:CEO全方位展望

第2章 市場概要

  • 市場概要:定義
  • 市場概要:區分
  • 類風濕性關節炎:全球的發病數量

第3章 外部影響:推動因素、阻礙因素──類風濕性關節炎治療市場整體的情況

  • 推動因素、阻礙因素

第4章 競爭分析:類風濕性關節炎治療市場整體的情況

  • 競爭要素、評估
  • 競爭情形:已上市及開發中產品的種類數
  • 競爭情形:已上市及開發中產品
  • 已上市產品分析
  • 專利失效的時間表
  • 開發中產品分析:臨床實驗中的產品
  • 產品上市的時間表
  • 第三階段臨床實驗的計劃:下期產品的上市

第5章 後期開發階段(即將上市)的產品簡介

  • 產品開發動態即時看板系統:Eli Lilly的Baricitinib
  • 產品開發動態即時看板系統:SANOFI/Regeneron的SAR153191/REGN88
  • 產品開發動態即時看板系統:BIOCAD的BCD-020

第6章 彙整

  • 結論-3大預測
  • 法律上的免責聲明

第7章 附錄

第8章 關於FROST & SULLIVAN

目錄
Product Code: NED2-01-00-00-00

Launch of Novel Oral Therapies to Result in Major Market Changes

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Companies to Watch
  • 4. Defining Healthcare Trends in the Future
  • 5. Executive Summary-CEO's Perspective

2. MARKET OVERVIEW

Market Overview

  • 1. Market Overview-Definitions
  • 2. Market Overview-Definitions (continued)
  • 3. Market Overview-Definitions (continued)
  • 4. Market Overview-Definitions (continued)
  • 5. Market Overview-Definitions (continued)
  • 6. Market Overview-Definitions (continued)
  • 7. Market Overview-Segmentation
  • 8. Market Overview-Segmentation (continued)
  • 9. Market Overview-Segmentation (continued)
  • 10. Rheumatoid Arthritis Global Incidence

3. EXTERNAL CHALLENGES: DRIVERS AND RESTRAINTS-TOTAL RHEUMATOID ARTHRITIS THERAPEUTICS MARKET

External Challenges: Drivers and Restraints-Total Rheumatoid Arthritis Therapeutics Market

  • 1. Drivers and Restraints

4. COMPETITIVE ANALYSIS-TOTAL RHEUMATOID ARTHRITIS THERAPEUTICS MARKET

Competitive Analysis-Total Rheumatoid Arthritis Therapeutics Market

  • 1. Competitive Factors and Assessment
  • 2. Competitive Landscape-Count of Marketed and Pipeline Products
  • 3. Competitive Landscape-Marketed and Pipeline Products
  • 4. Marketed Product Analysis
  • 5. Marketed Product Analysis (continued)
  • 6. Patent Expiration Timeline
  • 7. Pipeline Analysis-Products in Clinical Development
  • 8. Pipeline Analysis-Products in Clinical Development (continued)
  • 9. Pipeline Analysis-Products in Clinical Development (continued)
  • 10. Product Launch Timeline
  • 11. Phase 3 Clinical Program-Next Product Launches

5. PROFILES OF LATE-STAGE INVESTIGATIONAL PRODUCTS CLOSE TO BE LAUNCHED

Profiles of Late-stage Investigational Products Close to be Launched

  • 1. Product Dashboard-Eli Lilly's Baricitinib
  • 2. Product Dashboard-Sanofi/Regeneron's SAR153191/REGN88
  • 3. Product Dashboard-Biocad's BCD-020

6. THE LAST WORD

The Last Word

  • 1. The Last Word-Three Big Predictions
  • 2. The Last Word-Discussion
  • 3. Legal Disclaimer

7. APPENDIX

Appendix

  • 1. Methodology
  • 2. Table of Acronyms Used
  • 3. Table of Acronyms Used (continued)
  • 4. Table of Acronyms Used (continued)
  • 5. Drivers Explained
  • 6. Drivers Explained (continued)
  • 7. Drivers Explained (continued)
  • 8. Drivers Explained (continued)
  • 9. Restraints Explained
  • 10. Restraints Explained (continued)
  • 11. Additional Sources of Information on Rheumatoid Arthritis
  • 12. Additional Sources of Information on Rheumatoid Arthritis (continued)
  • 13. Learn More-Next Steps

8. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition-Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top